| Literature DB >> 28348734 |
Jennifer L Pecina1, Jennifer M Frank1, Frederick North2.
Abstract
INTRODUCTION: E-consultations are asynchronous text-based consultations between providers which can facilitate patient access to timely specialty care. In contrast to traditional face-to-face consults, conveying and completing recommendations of the specialist is the responsibility of the referring provider. This presents a new workflow for primary care providers who have multiple options (face-to-face, telephone, letter, secure message) to communicate the e-consultation recommendations. This study examines how primary care providers are managing this new workflow.Entities:
Keywords: E-consultation; primary care; remote consultation; tele-consultation; virtual consultation
Year: 2016 PMID: 28348734 PMCID: PMC5354179 DOI: 10.1177/2050312116682127
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Distribution of e-consultations by responding specialty (specialties comprising <2% not shown).
| E-consultation specialty (N = 1041) | Number of e-consultations (% of total) |
|---|---|
| Spine Center | 147 (14) |
| Gastroenterology & Hepatology | 145 (14) |
| Endocrinology | 120 (11) |
| Cardiovascular Diseases | 115 (11) |
| Neurology | 75 (7) |
| Hematology | 68 (6) |
| Pediatric and Adolescent Medicine | 66 (6) |
| Nephrology & Hypertension | 61 (6) |
| Psychiatry & Psychology | 50 (5) |
| Obstetrics and Gynecology | 38 (4) |
| Pulmonary & Critical Care Medicine | 38 (4) |
| Rheumatology | 29 (3) |
| Infectious Diseases | 26 (3) |
| Other specialties | 63 (6) |
Recommendation categories of 220 e-consultations.
| E-consultation recommendations (N = 220) | n (%) |
|---|---|
| Lab | 64 (29) |
| Imaging | 27 (12) |
| Procedure | 29 (13) |
| Medication | 78 (35) |
| Physical therapy | 12 (5) |
| F2F explicitly recommended | 38 (17) |
| F2F conditionally recommended | 48 (22) |
| Test surveillance type/interval | 39 (18) |
| More than one option of proceeding | 56 (25) |
| Other | 31 (14) |
| No recommendations/reassurance | 33 (15) |
F2F: face-to-face.
Percentages may add up to more than 100% as recommendations could be coded into more than one category.
Method of communication used to notify patient of e-consultation results and recommendations; total and by notifier.
| Method used for notification (N = 192) | All, n (%) | Provider notified, n (%) | Nurse/assistant notified, n (%) |
|---|---|---|---|
| Telephone | 115 (59) | 44 (23) | 71 (37) |
| Patient portal (secure message) | 46 (24) | 45 (23) | 1 (0.5) |
| Face-to-face visit with referring provider | 22 (11) | 22 (11) | None |
| Letter (by mail) | 9 (5) | 9 (5) | None |
Method of notification by category of e-consultation recommendation.
| E-consultation recommendations (N = 220) | Notified phone, n (%) | Notified by portal, n (%) | Notified at F2F visit, n (%) | Notified by letter, n (%) | No documented notification, n (%) | p value |
|---|---|---|---|---|---|---|
| Lab | 33 (52) | 14 (22) | 7 (11) | 1 (2) | 9 (14) | 0.79 |
| Imaging | 19 (70) | 2 (8) | 1 (4) | 1 (4) | 4 (12) | 0.20 |
| Procedure | 15 (52) | 7 (24) | 2 (7) | 2 (7) | 3 (10) | 0.86 |
| Medication | 44 (56) | 13 (17) | 8 (10) | 4 (5) | 9 (11) | 0.75 |
| Physical therapy | 8 (67) | 1 (8) | 1 (8) | 1 (8) | 1 (8) | 0.69 |
| F2F explicitly recommended | 17 (45) | 7 (18) | 4 (11) | 0 | 10 (26) | 0.05 |
| F2F conditionally recommended | 30 (62) | 8 (17) | 3 (6) | 0 | 7 (15) | 0.25 |
| Test surveillance type/interval | 17 (44) | 13 (33) | 1 (3) | 3 (8) | 5 (13) | 0.08 |
| More than one option of proceeding | 30 (54) | 10 (18) | 7 (12) | 3 (5) | 6 (11) | 0.85 |
| Other | 17 (55) | 5 (16) | 4 (13) | 2 (6) | 3 (10) | 0.83 |
| No recommendations/reassurance | 17 (51) | 19 (30) | 1 (3) | 2 (6) | 3 (9) | 0.37 |
F2F: face-to-face.
20% of cells have expected count less than 5, chi-square suspect.
Notifying team member by category of e-consultation recommendation.
| E-consultation recommendations (N = 220) | Notified by provider, n (%) | Notified by nursing staff, n (%) | No documented notification, n (%) | p value |
|---|---|---|---|---|
| Lab | 41 (64) | 15 (23) | 8 (12) | 0.15 |
| Imaging | 17 (63) | 7 (26) | 3 (11) | 0.66 |
| Procedure | 18 (62) | 8 (28) | 3 (10) | 0.71 |
| Medication | 41 (53) | 28 (35) | 9 (11) | 0.76 |
| Physical therapy | 5 (42) | 6 (50) | 1 (8) | 0.43 |
| F2F explicitly recommended | 19 (50) | 9 (24) | 10 (26) | 0.01 |
| F2F conditionally recommended | 25 (52) | 16 (33) | 7 (15) | 0.83 |
| Test surveillance type/interval | 26 (67) | 9 (23) | 4 (10) | 0.26 |
| More than one option of proceeding | 32 (57) | 19 (34) | 5 (9) | 0.68 |
| Other | 16 (52) | 12 (39) | 3 (9) | 0.72 |
| No recommendations/reassurance | 17 (51) | 13 (39) | 3 (11) | 0.63 |
F2F: face-to-face.
20% of cells have expected count less than 5, chi-square suspect.
Recommendation completion status of e-consultations where recommendations were made.
| E-consultation recommendations completed (N = 187) | n (%) |
|---|---|
| All | 146 (78) |
| None | 19 (10) |
| Partial | 11 (6) |
| Partial: patient declined some | 8 (4) |
| None: patient declined all | 3 (2) |